Study on Serum Zinc and Selenium Levels in Epileptic Patients

Generalized Epileptic Clinical Trial

Official title:

Arak University of Medical Sciences , Ministry of Health and Education,I.R.Iran

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01764516
• Other study ID #: f110@1958
• Secondary ID: f110@19588f110@1
• Status: Completed
• Phase: N/A
• First received: January 5, 2013
• Last updated: January 5, 2013
• Start date: November 2011
• Est. completion date: May 2012

Study information

• Verified date: January 2013
• Source: Arak University of Medical Sciences
• Contact: n/a
• Is FDA regulated: No
• Health authority: Iran: Ethics CommitteeIran: Ministry of Health
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This study was carried out with the purpose of evaluating zinc and selenium levels in serum of epileptic patients and compare with normal individuals.

Description:

Forty patients aged 18 to 50 years visiting Vali-Asr hospital in Arak, I.R. Iran, who were diagnosed with generalized form of epilepsy by a neurologist for the first time were recruited as cases. The control group (n=40) was selected from healthy individuals, in whom no disease was diagnosed until this study, and were matched to the case group by age, sex, and economical status.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: May 2012
• Est. primary completion date: March 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

New generalized and single epileptic cases patients who accept and sign the approval form of ethical committee non smoker, no trauma, no use of selenium supplement, no use of zinc supplement, no use of vitamin A supplement, no use of vitamin D supplement, no Weight loss, no Diarrhea, no addiction, no alcohol consumption, no use of certain medications,

Exclusion Criteria:

presence of above criteria as well as, generalized and single epileptic cases under treatment

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Epilepsy
• Generalized Epileptic

Locations

Country	Name	City	State
Iran, Islamic Republic of	Vali-Asr Hospital	Arak	Central province

Sponsors (1)

Lead Sponsor	Collaborator
Arak University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Study on Serum Zinc and Selenium Levels in Epileptic Patients	decrement in serum zinc and selenium level	5 months	Yes
Secondary	Comparison between the selenium levels by gender in two groups		5 months	Yes